{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:58:35Z","timestamp":1774306715358,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-05814-y","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T18:31:14Z","timestamp":1752777074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["PSA density correlates to pathology T stage and ISUP grade: insights from a cohort of 3568 radical prostatectomy cases"],"prefix":"10.1007","volume":"43","author":[{"given":"Maxime","family":"Pattou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"Neuzillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Ghoneim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Olivier","family":"Bosset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marie","family":"Herve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Vanalderwerelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Bohin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Marie","family":"Lugagne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanish","family":"Soorojebally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Lebret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"5814_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.urology.2017.04.015","volume":"105","author":"JS Jue","year":"2017","unstructured":"Jue JS et al (2017) Re-examining prostate-specific antigen (PSA) density: defining the optimal PSA range and patients for using PSA density to predict prostate cancer using extended template biopsy. Urology 105:123\u2013128. https:\/\/doi.org\/10.1016\/j.urology.2017.04.015","journal-title":"Urology"},{"issue":"2","key":"5814_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0090-4295(00)00637-3","volume":"56","author":"WJ Catalona","year":"2000","unstructured":"Catalona WJ et al (2000) Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology 56(2):255\u2013260. https:\/\/doi.org\/10.1016\/S0090-4295(00)00637-3","journal-title":"Urology"},{"key":"5814_CR3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2147\/RRU.S117963","volume":"8","author":"S Al-Khalil","year":"2016","unstructured":"Al-Khalil S, Ibilibor C, Cammack J, De Riese W (2016) Association of prostate volume with incidence and aggressiveness of prostate cancer. RRU 8:201\u2013205. https:\/\/doi.org\/10.2147\/RRU.S117963","journal-title":"RRU"},{"issue":"18","key":"5814_CR4","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1200\/jco.2007.25.18_suppl.5007","volume":"25","author":"S Rogosin","year":"2007","unstructured":"Rogosin S et al (2007) PSA density as a predictor of aggressive prostate cancer on repeat prostate biopsy. JCO 25(18):5007\u20135007. https:\/\/doi.org\/10.1200\/jco.2007.25.18_suppl.5007","journal-title":"JCO"},{"issue":"2","key":"5814_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.euo.2023.08.002","volume":"7","author":"S Wang","year":"2024","unstructured":"Wang S et al (2024) Diagnostic performance of prostate-specific antigen density for detecting clinically significant prostate cancer in the era of magnetic resonance imaging: a systematic review and meta-analysis. Eur Urol Oncol 7(2):189\u2013203. https:\/\/doi.org\/10.1016\/j.euo.2023.08.002","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"5814_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.juro.2006.09.039","volume":"177","author":"SD Kundu","year":"2007","unstructured":"Kundu SD, Roehl KA, Yu X, Antenor JAV, Suarez BK, Catalona WJ (2007) Prostate specific antigen density correlates with features of prostate cancer aggressiveness. J Urol 177(2):505\u2013509. https:\/\/doi.org\/10.1016\/j.juro.2006.09.039","journal-title":"J Urol"},{"issue":"16","key":"5814_CR7","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/pros.24078","volume":"80","author":"N Omri","year":"2020","unstructured":"Omri N et al (2020) Association between PSA density and pathologically significant prostate cancer: the impact of prostate. Prostate 80(16):1444\u20131449. https:\/\/doi.org\/10.1002\/pros.24078","journal-title":"Prostate"},{"issue":"4","key":"5814_CR8","first-page":"232","volume":"13","author":"S Saidi","year":"2009","unstructured":"Saidi S et al (2009) Does prostate specific antigen density correlates with aggressiveness of the prostate cancer? Hippokratia 13(4):232\u2013236","journal-title":"Hippokratia"},{"issue":"2","key":"5814_CR9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","volume":"40","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA (2016) The 2014 international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 40(2):244\u201325. https:\/\/doi.org\/10.1097\/PAS.0000000000000530","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"5814_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/003655998750015124","volume":"32","author":"E Ove Gustafsson","year":"1998","unstructured":"Ove Gustafsson E, Mansour U, Norming A (1998) Prostate-specific antigen (PSA), PSA density and age-adjusted PSA reference values in screening for prostate cancer: a study of a randomly selected population of 2400 men. Scand J Urol Nephrol 32(6):373\u2013377. https:\/\/doi.org\/10.1080\/003655998750015124","journal-title":"Scand J Urol Nephrol"},{"issue":"2","key":"5814_CR11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2307\/2532143","volume":"47","author":"JD Knoke","year":"1991","unstructured":"Knoke JD (1991) Nonparametric analysis of covariance for comparing change in randomized studies with baseline values subject to error. Biometrics 47(2):523\u2013533","journal-title":"Biometrics"},{"issue":"2","key":"5814_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.urology.2014.02.038","volume":"84","author":"Y-S Ha","year":"2014","unstructured":"Ha Y-S et al (2014) Prostate-specific antigen density toward a better cutoff to identify better candidates for active surveillance. Urology 84(2):365\u2013372. https:\/\/doi.org\/10.1016\/j.urology.2014.02.038","journal-title":"Urology"},{"issue":"2","key":"5814_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3390\/diagnostics11020335","volume":"11","author":"F Gentile","year":"2021","unstructured":"Gentile F et al (2021) Optimized identification of high-grade prostate cancer by combining different PSA molecular forms and PSA density in a deep learning model. Diagnostics 11(2):335. https:\/\/doi.org\/10.3390\/diagnostics11020335","journal-title":"Diagnostics"},{"issue":"1","key":"5814_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1464-410X.2011.10681.x","volume":"110","author":"NM Corcoran","year":"2012","unstructured":"Corcoran NM et al (2012) The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour. BJU Int 110(1):36\u201342. https:\/\/doi.org\/10.1111\/j.1464-410X.2011.10681.x","journal-title":"BJU Int"},{"issue":"4","key":"5814_CR15","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.juro.2011.05.082","volume":"186","author":"H Botto","year":"2011","unstructured":"Botto H, Neuzillet Y, Lebret T, Camparo P, Molinie V, Raynaud J-P (2011) High incidence of predominant gleason pattern 4 localized prostate cancer is associated with low serum testosterone. J Urol 186(4):1400\u20131405. https:\/\/doi.org\/10.1016\/j.juro.2011.05.082","journal-title":"J Urol"},{"issue":"4","key":"5814_CR16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/pcan.2015.44","volume":"18","author":"A Pichon","year":"2015","unstructured":"Pichon A et al (2015) Preoperative low serum testosterone is associated with high-grade prostate cancer and an increased Gleason score upgrading. Prostate Cancer Prostatic Dis 18(4):382\u2013387. https:\/\/doi.org\/10.1038\/pcan.2015.44","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"13","key":"5814_CR17","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1158\/1538-7445.AM2018-3746","volume":"78","author":"Y Wu","year":"2018","unstructured":"Wu Y et al (2018) Abstract 3746: Targeting adrenal androgen to treat prostate cancer. Cancer Res 78(13):3746\u20133746. https:\/\/doi.org\/10.1158\/1538-7445.AM2018-3746","journal-title":"Cancer Res"},{"issue":"2","key":"5814_CR18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ijrobp.2015.01.051","volume":"92","author":"JM Caster","year":"2015","unstructured":"Caster JM, Falchook AD, Hendrix LH, Chen RC (2015) Risk of pathologic upgrading or locally advanced disease in early prostate cancer patients based on biopsy gleason score and PSA: a population-based study of modern patients. Int J Radiat Oncol Biol Phys 92(2):244\u2013251. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.01.051","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5814_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.urology.2017.07.071","volume":"111","author":"A Brassetti","year":"2018","unstructured":"Brassetti A et al (2018) Prostate-specific Antigen Density Is a Good Predictor of Upstaging and Upgrading, According to the New Grading System: The Keys We Are Seeking May Be Already in Our Pocket. Urology 111:129\u2013135. https:\/\/doi.org\/10.1016\/j.urology.2017.07.071","journal-title":"Urology"},{"issue":"4","key":"5814_CR20","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3390\/jcm12041659","volume":"12","author":"C Huang","year":"2023","unstructured":"Huang C, He S, He Q, Gong Y, Song G, Zhou L (2023) Determination of whether apex or non-apex prostate cancer is the best candidate for the use of prostate-specific antigen density to predict pathological grade group upgrading and upstaging after radical prostatectomy. JCM 12(4):1659. https:\/\/doi.org\/10.3390\/jcm12041659","journal-title":"JCM"},{"issue":"16","key":"5814_CR21","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/pros.23069","volume":"75","author":"D Zapata","year":"2015","unstructured":"Zapata D, Howard LE, Allott EH, Hamilton RJ, Goldberg K, Freedland SJ (2015) Is PSA related to serum cholesterol and does the relationship differ between black and white men?\u00a0PSA and cholesterol relationship by race. Prostate 75(16):1877\u20131885. https:\/\/doi.org\/10.1002\/pros.23069","journal-title":"Prostate"},{"issue":"5","key":"5814_CR22","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.urology.2010.03.044","volume":"76","author":"B Akduman","year":"2010","unstructured":"Akduman B, Tandberg DJ, O\u2019Donnell CI, Hughes A, Moyad MA, Crawford ED (2010) Effect of statins on serum prostate-specific antigen levels. Urology 76(5):1048\u20131051. https:\/\/doi.org\/10.1016\/j.urology.2010.03.044","journal-title":"Urology"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05814-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05814-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05814-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:02:48Z","timestamp":1767996168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05814-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5814"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05814-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6214991\/v1","asserted-by":"object"}]},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All patients gave informed consent, the study was approved by the Foch hospital ethics committee (IRB00012437). The study was conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"445"}}